Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02024997 · ClinicalTrials.gov registry record · Early Phase 1

Improving Pancreas Radiotherapy Plans Using Respiration-driven Anatomic Deformation: A Pilot Study

A Early Phase 1 study, sponsored by Cedars-Sinai Medical Center.

Completed
Registry status
Early Phase 1
Development phase
15
Enrollment target

NCT02024997 is a Early Phase 1 study that has completed, run by Cedars-Sinai Medical Center. The registered enrollment target is 15 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02024997, a Early Phase 1 study, has completed, sponsored by Cedars-Sinai Medical Center.

COMPLETED
Registry status
Early Phase 1
Development phase
15 participants
Enrollment target

Study Summary

The overall aim of this study is to investigate a novel "dual instance" planning method to make use of the respiratory motion to improve pancreatic radiation therapy (RT) treatment planning. Specific Aim 1: Acquire patient abdominal MRI and CT at both deep inspiration (INSP) and expiration (EXP) positions and characterize the changes in geometric relationships between the INSP and EXP instances for tumor and normal tissues including stomach, duodenum and bowel. We hypothesize that INSP and EXP MRI and CT characterization will allow identification of patients who may benefit from the dual instance planning method. Specific Aim 2: Develop, investigate and evaluate plans based on free breathing, single instance breath hold, and the novel dual instance anatomical information. We hypothesize that use of the dual instance method will lead to improved plans, demonstrated by the ability to increase dose to the target, while maintaining the clinically-accepted normal tissue dose constraints.

Interventions

  • OTHER Magnetic Resonance Imaging (MRI)

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2013-01
Phase Early Phase 1

Sponsor

Cedars-Sinai Medical Center

339 total trials

What the Registry Record Tells You About NCT02024997

The ClinicalTrials.gov registry entry for NCT02024997 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cedars-Sinai Medical Center, which has 339 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Magnetic Resonance Imaging (MRI) is the first listed.

NCT02024997 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02024997 about?

NCT02024997 is a clinical study titled "Improving Pancreas Radiotherapy Plans Using Respiration-driven Anatomic Deformation: A Pilot Study". The overall aim of this study is to investigate a novel "dual instance" planning method to make use of the respiratory motion to improve pancreatic radiation therapy (RT) treatment planning. Specific Aim 1: Acquire patient abdominal MRI and CT at both deep inspiration (INSP) and expiration (EXP) po...

What is the current status of trial NCT02024997?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 15 participants. The study started on 2013-01.

What interventions are being tested in trial NCT02024997?

The interventions under investigation include: Magnetic Resonance Imaging (MRI) (OTHER).

Who is sponsoring clinical trial NCT02024997?

This trial is sponsored by Cedars-Sinai Medical Center, which has 339 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.